Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, FGFR1 or PCM1-JAK2

被引：51
作者：
Baer, Constance [1 ]
Muehlbacher, Verena [1 ]
Kern, Wolfgang [1 ]
Haferlach, Claudia [1 ]
Haferlach, Torsten [1 ]
机构：
[1] MLL Munich Leukemia Lab, Munich, Germany
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 08期
关键词：
MYELOID NEOPLASMS; IMATINIB; FUSION;
D O I：
10.3324/haematol.2017.187302
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E348 / E350
页数：3
相关论文
共 15 条
[1]  
[Anonymous], MYELOID LYMPHOID NEO
[2]  
[Anonymous], LEUKEMIA
[3]   Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta [J].
Apperley, JF ;
Gardembas, M ;
Melo, JV ;
Russell-Jones, R ;
Bain, BJ ;
Baxter, J ;
Chase, A ;
Chessells, JM ;
Colombat, M ;
Dearden, CE ;
Dimitrijevic, S ;
Mahon, FX ;
Marin, D ;
Nikolova, Z ;
Olavarria, E ;
Silberman, S ;
Schultheis, B ;
Cross, NCP ;
Goldman, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :481-487
[4]   The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].
Arber, Daniel A. ;
Orazi, Attilio ;
Hasserjian, Robert ;
Thiele, Jurgen ;
Borowitz, Michael J. ;
Le Beau, Michelle M. ;
Bloomfield, Clara D. ;
Cazzola, Mario ;
Vardiman, James W. .
BLOOD, 2016, 127 (20) :2391-2405
[5]   A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment [J].
Buijs, Arjan ;
van Wijnen, Merel ;
van den Blink, Dorine ;
van Gijn, Marielle ;
Klein, Saskia K. .
CANCER GENETICS, 2013, 206 (04) :140-144
[6]   A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J].
Cools, J ;
DeAngelo, DJ ;
Gotlib, J ;
Stover, EH ;
Legare, RD ;
Cortes, J ;
Kutok, J ;
Clark, J ;
Galinsky, I ;
Griffin, JD ;
Cross, NCP ;
Tefferi, A ;
Malone, J ;
Alam, R ;
Schrier, SL ;
Schmid, J ;
Rose, M ;
Vandenberghe, P ;
Verhoef, G ;
Boogaerts, M ;
Wlodarska, I ;
Kantarjian, H ;
Marynen, P ;
Coutre, SE ;
Stone, R ;
Gilliland, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) :1201-1214
[7]   Acute Myeloid Leukemia [J].
Doehner, Hartmut ;
Weisdorf, Daniel J. ;
Bloomfield, Clara D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (12) :1136-1152
[8]   World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management [J].
Gotlib, Jason .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) :1243-1259
[9]   Myeloid and Lymphoid Neoplasm With Abnormalities of FGFR1 Presenting With Trilineage Blasts and RUNX1 Rearrangement: A Case Report and Review of Literature [J].
Kumar, Kirthi R. ;
Chen, Weina ;
Koduru, Prasad R. ;
Luu, Hung S. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (05) :738-748
[10]   Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia [J].
Meggendorfer, Manja ;
Haferlach, Torsten ;
Alpermann, Tamara ;
Jeromin, Sabine ;
Haferlach, Claudia ;
Kern, Wolfgang ;
Schnittger, Susanne .
HAEMATOLOGICA, 2014, 99 (12)
12